Anthony Hayes

This profile gathers the share dealings of Anthony Hayes across 2 companies, led by Dominari Holdings Inc. and Hoth Therapeutics, Inc. Over a trading history stretching from 11 April 2014 to 11 September 2026, the count stands at 60 filings.

In open-market terms, that means 47 purchases worth €1.2M on one side and 2 sales worth €455k on the other. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 share grants. In 2026 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €6,469. Of 44 purchases, 31 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 14 September 2026, the filings show an open-market purchase worth €93k in Dominari Holdings Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.